Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05958160Phase 3Unknown
Phase 3, randomised, open-label trial in infantile epileptic spasms syndrome (IESS) (2 arms), sponsored by Lady Hardinge Medical College. Primary endpoint: Proportion of children with ≥ 50% reduction in clinical spasms at 12 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05958160.